Virus-like nanoparticles for oral delivery
US12234260B2 · kind B2 · utility
0Cited by
3References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2022 |
| Grant date | Feb 25, 2025 |
| Priority date | — |
| Expiry date | Dec 18, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/28123
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A Hepatitis E virus (HEV)-based virus like nanoparticle (HEVNP) made with a modified capsid protein containing at least a portion of open reading frame 2 (ORF2) protein conjugated with gold nanocluster is provided. Also provided are methods of targeted delivery of a nucleic acid using the HEVNP.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.